Skip to content

Drug interactions

Erdafitinib + Memantine

Severity: Minor

Erdafitinib and Memantine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib may inhibit OCT2-mediated renal secretion of memantine, which could raise memantine levels. Higher exposure may cause dizziness, confusion and other CNS effects.

What this interaction means in plain words

Erdafitinib and Memantine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Erdafitinib belongs to Oncology; Memantine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Inhibition of renal tubular OCT2 transport reduces memantine renal clearance.

What to do

Watch for dizziness, confusion or agitation, and lower the memantine dose if these appear, particularly in patients with renal impairment.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Memantine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Memantine?

MediHelp rates the interaction as minor. Erdafitinib and Memantine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Erdafitinib may inhibit OCT2-mediated renal secretion of memantine, which could raise memantine levels. Higher exposure may cause dizziness, confusion and other CNS effects.

How serious is the interaction between Erdafitinib and Memantine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Watch for dizziness, confusion or agitation, and lower the memantine dose if these appear, particularly in patients with renal impairment.

What other medicines interact with Memantine?

MediHelp also lists interactions of Memantine with, for example, Ketamine, Acetazolamide, Aluminum hydroxide. The full list is on the Memantine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in